This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
I can't seem to find a definite answer to this. Does anyone know what the lastest update on kalydeco for ddf508 mutation is? I have heard 2014 sometime does anyone know anymore info? Anything would help thank you
I can't seem to find a definite answer to this. Does anyone know what the lastest update on kalydeco for ddf508 mutation is? I have heard 2014 sometime does anyone know anymore info? Anything would help thank you
I assume you mean Kalydeco with VX809 - the new drug from Vertex Pharmaceuticals that targets the DeltaF508 gene. It is in phase 3 clinical trials at this time and from what I hear meeting all the endpoints.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.